Division of Solid Tumor Oncology

Are you a medical student eager to explore the cutting-edge field of thoracic oncology? If so, the Thoracic Malignancy Group at the Sidney Kimmel Comprehensive Cancer Center is  pioneering a multidisciplinary initiative dedicated to advancing the treatment of lung and aerodigestive cancers.

As a student under the leadership of the Medical Director of Bodine Infusion, Clinical Co-Director of the Phase 1 Program/Early Drug Development Office, and Lung Program Leader at Jefferson Health, Sarah Gordon, MD, the Thoracic Malignancy Group is transforming cancer care. As a member of our team, you will play a pivotal role in shaping the future of cancer treatments, collaborating with experts such as Rita Axelrod, MD, a medical oncologist specializing in malignancies of the head, neck, lung, and esophagus. Dr. Axelrod’s research focuses on improving treatment outcomes through precision medicine and personalized treatment strategies, offering you the chance to contribute to innovative, patient-centered care.

The program integrates cutting-edge advancements in technology, precision medicine, and innovative therapies to provide the most effective and tailored treatments for patients. Our approach to care is highly collaborative, with oncologists, surgeons, radiation specialists, pulmonologists, pathologists, nurses, and researchers working together to develop personalized treatment strategies that leverage the latest therapies.

As a team member, you’ll gain invaluable hands-on clinical experience and be immersed in groundbreaking research that shapes the future of thoracic malignancies. Whether assisting with patient care or exploring new therapeutic options, you’ll be directly involved in delivering state-of-the-art treatments that significantly impact patient outcomes. This is a unique opportunity to learn in an environment that bridges clinical practice with cutting-edge research, offering a well-rounded, high-impact educational experience.

One of the program's standout features is the chance to engage in innovative clinical research, including access to the latest clinical trials focused on immunotherapy, targeted drug therapies, and advanced treatment modalities. You will collaborate with the team on techniques like minimally invasive surgery, radiation therapy, and genetic profiling-based personalized therapies. Additionally, you will contribute to pioneering early detection methods and preventative strategies for lung cancer, making a tangible difference in thoracic oncology.

This is more than just an opportunity to learn—it's a chance to collaborate with top-tier professionals, shape the future of cancer care, and make a lasting impact on patients' lives. Join us today and be part of a team that’s driving tomorrow’s breakthroughs in thoracic oncology.